{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T07:00:04Z","timestamp":1776582004445,"version":"3.51.2"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Clinical Trials from the Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University","award":["No. 2021-LCYJ-MS-11"],"award-info":[{"award-number":["No. 2021-LCYJ-MS-11"]}]},{"name":"Nanjing Drum Tower Hospital National Natural Science Foundation Youth Cultivation Project","award":["No. 2024-JCYJ-QP-15"],"award-info":[{"award-number":["No. 2024-JCYJ-QP-15"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"DOI":"10.1186\/s13550-026-01384-1","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T17:35:04Z","timestamp":1770226504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early prognostic stratification of follicular lymphoma through \u00b9\u2078F-FDG PET\/CT tumor metabolic parameters and clinical characteristics"],"prefix":"10.1186","volume":"16","author":[{"given":"Shao-Chun","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9825-7909","authenticated-orcid":false,"given":"Xin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8425-3771","authenticated-orcid":false,"given":"Jian","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"issue":"8","key":"1384_CR1","doi-asserted-by":"publisher","first-page":"e0272787","DOI":"10.1371\/journal.pone.0272787","volume":"17","author":"\u00c1 J\u00f3na","year":"2022","unstructured":"J\u00f3na \u00c1, Kenyeres A, Barna S, Ill\u00e9s \u00c1, Simon Z. Clinical and biological prognostic factors in follicular lymphoma patients. PLoS ONE. 2022;17(8):e0272787.","journal-title":"PLoS ONE"},{"issue":"12","key":"1384_CR2","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1002\/ajh.26737","volume":"97","author":"E Jacobsen","year":"2022","unstructured":"Jacobsen E. Follicular lymphoma: 2023 update on diagnosis and management. Am J Hematol. 2022;97(12):1638\u201351.","journal-title":"Am J Hematol"},{"issue":"11","key":"1384_CR3","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1182\/blood.2020010263","volume":"139","author":"C Casulo","year":"2022","unstructured":"Casulo C, Dixon JG, Le-Rademacher J, Hoster E, Hochster HS, Hiddemann W, et al. Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials. Blood. 2022;139(11):1684\u201393.","journal-title":"Blood"},{"issue":"23","key":"1384_CR4","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1200\/JCO.2014.59.7534","volume":"33","author":"C Casulo","year":"2015","unstructured":"Casulo C, Byrtek M, Dawson KL, Zhou X, Farber CM, Flowers CR, et al. Early relapse of follicular lymphoma after rituximab plus Cyclophosphamide, Doxorubicin, Vincristine, and prednisone defines patients at high risk for death: an analysis from the National lymphocare study. J Clin Oncol. 2015;33(23):2516\u201322.","journal-title":"J Clin Oncol"},{"issue":"7","key":"1384_CR5","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1007\/s12325-021-01738-2","volume":"38","author":"E Bachy","year":"2021","unstructured":"Bachy E, Rufibach K, Parreira J, Launonen A, Nielsen T, Hackshaw A. Phase III clinical trials in First-Line follicular lymphoma: A review of their design and interpretation. Adv Ther. 2021;38(7):3489\u2013505.","journal-title":"Adv Ther"},{"issue":"3","key":"1384_CR6","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s00277-024-06079-y","volume":"104","author":"X Li","year":"2025","unstructured":"Li X, Wang X. Effect of POD24 on the prognosis of follicular and other indolent B-cell non-hodgkin lymphomas. Ann Hematol. 2025;104(3):1427\u201342.","journal-title":"Ann Hematol"},{"issue":"2","key":"1384_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.clml.2021.08.004","volume":"22","author":"DS Nogueira","year":"2022","unstructured":"Nogueira DS, Lage L, Culler HF, Pereira J. Follicular lymphoma: refining prognostic models and impact of Pod-24 in clinical outcomes. Clin Lymphoma Myeloma Leuk. 2022;22(2):67\u201375.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"1384_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11864-025-01297-6","volume":"26","author":"S Cheng","year":"2025","unstructured":"Cheng S, Liu Y. Advances in personalized treatment and prognostic factors of follicular lymphoma. Curr Treat Options Oncol. 2025;26(4):313\u201330.","journal-title":"Curr Treat Options Oncol"},{"key":"1384_CR9","doi-asserted-by":"publisher","first-page":"100865","DOI":"10.1016\/j.blre.2021.100865","volume":"50","author":"P Mozas","year":"2021","unstructured":"Mozas P, Rivero A, L\u00f3pez-Guillermo A. Past, present and future of prognostic scores in follicular lymphoma. Blood Rev. 2021;50:100865.","journal-title":"Blood Rev"},{"issue":"1","key":"1384_CR10","doi-asserted-by":"publisher","first-page":"e70010","DOI":"10.1002\/hon.70010","volume":"43","author":"A Zduniak","year":"2025","unstructured":"Zduniak A, L\u00e9v\u00eaque E, Draye-Carbonnier S, Becker S, Tonnelet D, Dubois S, et al. Combining total metabolic tumor volume with Beta-2-Microglobulin levels predicts outcomes in High-Burden follicular lymphoma patients. Hematol Oncol. 2025;43(1):e70010.","journal-title":"Hematol Oncol"},{"issue":"1","key":"1384_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40364-024-00716-4","volume":"13","author":"J Zha","year":"2025","unstructured":"Zha J, Chen Q, Zhang W, Jing H, Ye J, Liu H, et al. A machine learning-based model to predict POD24 in follicular lymphoma: a study by the Chinese workshop on follicular lymphoma. Biomark Res. 2025;13(1):2.","journal-title":"Biomark Res"},{"issue":"8","key":"1384_CR12","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1182\/blood-2016-05-717355","volume":"128","author":"V Jurinovic","year":"2016","unstructured":"Jurinovic V, Kridel R, Staiger AM, Szczepanowski M, Horn H, Dreyling MH, et al. Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy. Blood. 2016;128(8):1112\u201320.","journal-title":"Blood"},{"issue":"9","key":"1384_CR13","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","volume":"16","author":"A Pastore","year":"2015","unstructured":"Pastore A, Jurinovic V, Kridel R, Hoster E, Staiger AM, Szczepanowski M, et al. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. Lancet Oncol. 2015;16(9):1111\u201322.","journal-title":"Lancet Oncol"},{"key":"1384_CR14","doi-asserted-by":"publisher","first-page":"103418","DOI":"10.1016\/j.critrevonc.2021.103418","volume":"164","author":"J Jelicic","year":"2021","unstructured":"Jelicic J, Stauffer Larsen T, Bukumiric Z, Andjelic B. The clinical applicability of current prognostic models in follicular lymphoma: A systematic review. Crit Rev Oncol Hematol. 2021;164:103418.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"20","key":"1384_CR15","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1002\/cncr.33772","volume":"127","author":"ME Juweid","year":"2021","unstructured":"Juweid ME, Mueller M, Alhouri A, Arisheq MZ, Mottaghy FM. Positron emission tomography\/computed tomography in the management of hodgkin and B-cell non-Hodgkin lymphoma: an update. Cancer. 2021;127(20):3727\u201341.","journal-title":"Cancer"},{"key":"1384_CR16","doi-asserted-by":"publisher","first-page":"1136687","DOI":"10.3389\/fonc.2023.1136687","volume":"13","author":"X Chen","year":"2023","unstructured":"Chen X, Yuan T, Wei M, Yu B, Zhou N, Zhu H, et al. Diagnostic performance of integrated whole-body 18F-FDG PET\/MRI for detecting bone marrow involvement in indolent lymphoma: comparison with 18F-FDG PET or MRI alone. Front Oncol. 2023;13:1136687.","journal-title":"Front Oncol"},{"issue":"6","key":"1384_CR17","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00259-017-3914-y","volume":"45","author":"T Salomon","year":"2018","unstructured":"Salomon T, Nganoa C, Gac A-C, Fruchart C, Damaj G, Aide N, et al. Assessment of alteration in liver 18F-FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score. Eur J Nucl Med Mol Imaging. 2018;45(6):941\u201350.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1384_CR18","doi-asserted-by":"publisher","first-page":"6871","DOI":"10.2147\/CMAR.S216445","volume":"11","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhao Z, Li J, Zhang B, Sang S, Wu Y, et al. Prognostic values of baseline, interim and end-of therapy 18F-FDG PET\/CT in patients with follicular lymphoma. Cancer Manag Res. 2019;11:6871\u201385.","journal-title":"Cancer Manag Res"},{"issue":"12","key":"1384_CR19","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.3390\/cancers13122876","volume":"13","author":"GM Assanto","year":"2021","unstructured":"Assanto GM, Ciotti G, Brescini M, De Luca ML, Annechini G, D\u2019Elia GM, et al. High basal maximal standardized uptake value (SUVmax) in follicular lymphoma identifies patients with a low risk of Long-Term relapse. Cancers (Basel). 2021;13(12):2876.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1384_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3324\/haematol.2020.263194","volume":"107","author":"C Rossi","year":"2022","unstructured":"Rossi C, Tosolini M, Gravelle P, Pericart S, Kanoun S, Evrard S, et al. Baseline SUVmax is related to tumor cell proliferation and patient outcome in follicular lymphoma. Haematologica. 2022;107(1):221\u201330.","journal-title":"Haematologica"},{"issue":"4","key":"1384_CR21","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.4143\/crt.2018.649","volume":"51","author":"JH Liang","year":"2019","unstructured":"Liang JH, Zhang YP, Xia J, Ding CY, Wu W, Wang L, et al. Prognostic value of baseline and interim total metabolic tumor volume and total lesion Glycolysis measured on 18F-FDG PET-CT in patients with follicular lymphoma. Cancer Res Treat. 2019;51(4):1479\u201387.","journal-title":"Cancer Res Treat"},{"issue":"22","key":"1384_CR22","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1182\/blood-2017-11-816298","volume":"131","author":"AS Cottereau","year":"2018","unstructured":"Cottereau AS, Versari A, Luminari S, Dupuis J, Chartier L, Casasnovas RO, et al. Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA\/FIL study. Blood. 2018;131(22):2449\u201353.","journal-title":"Blood"},{"issue":"30","key":"1384_CR23","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1200\/JCO.2016.66.9440","volume":"34","author":"M Meignan","year":"2016","unstructured":"Meignan M, Cottereau AS, Versari A, Chartier L, Dupuis J, Boussetta S, et al. Baseline metabolic tumor volume predicts outcome in High-Tumor-Burden follicular lymphoma: A pooled analysis of three multicenter studies. J Clin Oncol. 2016;34(30):3618\u201326.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1384_CR24","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1053\/j.semnuclmed.2022.11.001","volume":"53","author":"L Zanoni","year":"2023","unstructured":"Zanoni L, Bezzi D, Nanni C, Paccagnella A, Farina A, Broccoli A, et al. PET\/CT in Non-Hodgkin lymphoma: an update. Semin Nucl Med. 2023;53(3):320\u201351.","journal-title":"Semin Nucl Med"},{"issue":"1","key":"1384_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2967\/jnumed.119.229450","volume":"61","author":"AS Cottereau","year":"2020","unstructured":"Cottereau AS, Nioche C, Dirand AS, Clerc J, Morschhauser F, Casasnovas O, et al. 18F-FDG PET dissemination features in diffuse large B-Cell lymphoma are predictive of outcome. J Nucl Med. 2020;61(1):40\u20135.","journal-title":"J Nucl Med"},{"issue":"3","key":"1384_CR26","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.21037\/qims-24-1504","volume":"15","author":"Q Jiang","year":"2025","unstructured":"Jiang Q, Lin Z, Chen Q, Lin F, Jiang C, Deng M, et al. Integration of PET\/CT parameters and a clinical variable to predict the risk of progression of disease within 24 months (POD24) in follicular lymphoma. Quant Imaging Med Surg. 2025;15(3):2468\u201380.","journal-title":"Quant Imaging Med Surg"},{"issue":"7","key":"1384_CR27","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1007\/s00259-025-07090-9","volume":"52","author":"C Jiang","year":"2025","unstructured":"Jiang C, Jiang Z, Zhang Z, Huang H, Zhou H, Jiang Q, et al. An explainable transformer model integrating PET and tabular data for histologic grading and prognosis of follicular lymphoma: a multi-institutional digital biopsy study. Eur J Nucl Med Mol Imaging. 2025;52(7):2384\u201396.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1384_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12885-025-13507-3","volume":"25","author":"Z Wen","year":"2025","unstructured":"Wen Z, Gao X, Wu Q, Yang J, Sun J, Wu K, et al. Baseline [18F]FDG PET\/CT radiomics for predicting interim efficacy in follicular lymphoma treated with first-line R-CHOP. BMC Cancer. 2025;25(1):128.","journal-title":"BMC Cancer"},{"issue":"3","key":"1384_CR29","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/bjh.18423","volume":"199","author":"A Rajam\u00e4ki","year":"2022","unstructured":"Rajam\u00e4ki A, Hujo M, Sund R, Prusila REI, Kuusisto MEL, Kuitunen H, et al. Link between disease status at 24 months and mortality in follicular lymphoma. Br J Haematol. 2022;199(3):458\u201362.","journal-title":"Br J Haematol"},{"issue":"8","key":"1384_CR30","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1182\/blood.2024027727","volume":"146","author":"A Claudel","year":"2025","unstructured":"Claudel A, Cottereau AS, Bachy E, Itti E, Feugier P, Rossi C, et al. Combined PET and ctdna response as a predictor of POD24 for follicular lymphoma after first-line induction treatment. Blood. 2025;146(8):913\u201325.","journal-title":"Blood"},{"issue":"7","key":"1384_CR31","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3390\/cancers17071065","volume":"17","author":"M Poza","year":"2025","unstructured":"Poza M, Martin-Mu\u00f1oz A, L\u00f3pez-Pereira P, Figaredo G, Zamanillo I, \u00cd\u00f1iguez R, et al. Exploratory study to evaluate the impact of interim PET\/CT assessment in First-Line follicular lymphoma. Cancers (Basel). 2025;17(7):1065.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1384_CR32","doi-asserted-by":"publisher","first-page":"8033","DOI":"10.1038\/s41598-024-58412-0","volume":"14","author":"S Draye-Carbonnier","year":"2024","unstructured":"Draye-Carbonnier S, Camus V, Becker S, Tonnelet D, L\u00e9v\u00eaque E, Zduniak A, et al. Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma. Sci Rep. 2024;14(1):8033.","journal-title":"Sci Rep"},{"issue":"1","key":"1384_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1182\/blood-2017-11-816405","volume":"132","author":"E Bachy","year":"2018","unstructured":"Bachy E, Maurer MJ, Habermann TM, Gelas-Dore B, Maucort-Boulch D, Estell JA, et al. A simplified scoring system in de Novo follicular lymphoma treated initially with immunochemotherapy. Blood. 2018;132(1):49\u201358.","journal-title":"Blood"},{"issue":"8","key":"1384_CR34","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1182\/bloodadvances.2022007949","volume":"7","author":"JJ Rodr\u00edguez-Sevilla","year":"2023","unstructured":"Rodr\u00edguez-Sevilla JJ, Fern\u00e1ndez-Rodr\u00edguez C, Bento L, Diez-Feij\u00f3o R, Pinz\u00f3n S, Gibert J, et al. Evaluation of 4 prognostic indices in follicular lymphoma treated in first line with immunochemotherapy. Blood Adv. 2023;7(8):1606\u201314.","journal-title":"Blood Adv"},{"key":"1384_CR35","doi-asserted-by":"publisher","first-page":"1090610","DOI":"10.3389\/fonc.2023.1090610","volume":"13","author":"J Hu","year":"2023","unstructured":"Hu J, Gao F, Zhao J, Song W, Wang Y, Zheng Y, et al. The prognostic index PRIMA-PI combined with Ki67 as a better predictor of progression of disease within 24 months in follicular lymphoma. Front Oncol. 2023;13:1090610.","journal-title":"Front Oncol"},{"key":"1384_CR36","doi-asserted-by":"publisher","first-page":"943151","DOI":"10.3389\/fonc.2022.943151","volume":"12","author":"H Li","year":"2022","unstructured":"Li H, Wang M, Zhang Y, Hu F, Wang K, Wang C, Gao Z. Prediction of prognosis and pathologic grade in follicular lymphoma using 18F-FDG PET\/CT. Front Oncol. 2022;12:943151.","journal-title":"Front Oncol"},{"issue":"1","key":"1384_CR37","doi-asserted-by":"publisher","first-page":"33914","DOI":"10.1038\/s41598-025-08223-8","volume":"15","author":"C Cui","year":"2025","unstructured":"Cui C, Cao J, Li Y, Jia B, Ma N, Li X, et al. A proof of concept study of 18F-FDG PET\/CT patient-level radiomics identify refractory\/relapsed diffuse large B-cell lymphoma. Sci Rep. 2025;15(1):33914.","journal-title":"Sci Rep"},{"issue":"3","key":"1384_CR38","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00277-023-05547-1","volume":"103","author":"A Aksu","year":"2024","unstructured":"Aksu A, K\u00fc\u00e7\u00fcker KA, Solmaz \u015e, Turgut B. A different perspective on PET\/CT before treatment in patients with hodgkin lymphoma: importance of volumetric and dissemination parameters. Ann Hematol. 2024;103(3):813\u201322.","journal-title":"Ann Hematol"},{"issue":"7","key":"1384_CR39","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1007\/s00330-025-11360-3","volume":"35","author":"F Kleiburg","year":"2025","unstructured":"Kleiburg F, de Geus-Oei LF, Spijkerman R, Noortman WA, van Velden FHP, Manohar S, et al. Baseline PSMA PET\/CT parameters predict overall survival and treatment response in metastatic castration-resistant prostate cancer patients. Eur Radiol. 2025;35(7):4223\u201332.","journal-title":"Eur Radiol"},{"issue":"5","key":"1384_CR40","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/diagnostics15050647","volume":"15","author":"\u00c1 J\u00f3na","year":"2025","unstructured":"J\u00f3na \u00c1, Kiss E, Ill\u00e9s \u00c1. Prognostication of follicular lymphoma: A review of prognostic scores and factors. Diagnostics (Basel). 2025;15(5):647.","journal-title":"Diagnostics (Basel)"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-026-01384-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-026-01384-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-026-01384-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:39:04Z","timestamp":1772793544000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13550-026-01384-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1384"],"URL":"https:\/\/doi.org\/10.1186\/s13550-026-01384-1","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This retrospective study was conducted at Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, approved by the Institutional Ethics Committee (Approval No: 2024-851-01) with waived informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This retrospective study utilized anonymized patient data and was granted a waiver of informed consent by the Institutional Ethics Committee (Approval No: 2024-851-01). All data were de-identified prior to analysis to ensure participant confidentiality.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}